न्यूरोएंडोक्राइन ट्यूमर

Gastro-enteropancreatic Neuro-endocrine tumors (GEP-NETs) are rare slow-growing cancers which commonly involve the abdominal organs like liver, stomach, intestines and pancreas. Their incidence has been documented to have increased over the last decade, thus resulting in treatment options being developed to treat these cancers. These cancers spread commonly to the liver, followed by lungs, bones and other sites. Depending on the extent of disease seen on scan, treatment is planned. Patients are advised Peptide Receptor Radionuclide Therapy (PRRT), which is the current standard of treatment for…

Sponsor: Tata Memorial Hospital
ClinicalTrials.gov पर NCT07404176
रजिस्ट्री पर आखिरी अपडेट 11 Feb 2026 · हमने 20 Oct 2026 को पढ़ा